• 2700 S Quincy St. Suite #500
    Arlington, VA 22206
  • Call Us
    443. 979.7550
  • Open Hours
    Monday - Friday: 7:00AM - 6:00PM (by appointment)

Why the Renaming of Polycystic Ovarian Syndrome (PCOS) to PMOS Is a Turning Point for Women's Health

Author: Laurena L. White, MD, MPH, DiplAc

If you’ve been diagnosed with polycystic ovarian syndrome (PCOS) or suspected you might have it,  you’ve likely experienced the confusion that comes with the name itself. Cysts?  Many women with this condition never have visible cysts on ultrasound. So what’s really going on?

What This Means for Integrative Reproductive Medicine
 
This is where integrative medicine, and the philosophy at the heart of The Eudaimonia Center, comes into sharpest focus. A condition now formally recognized as polyendocrine and metabolic demands a care model that goes beyond prescribing birth control pills to “regulate” a menstrual cycle. It requires looking at the whole woman: her hormonal landscape, her insulin sensitivity, her inflammatory burden, her stress response, and… her lived experience.

Since 2010, I have been screaming from the rooftops that PCOS is a METABOLIC condition with REPRODUCTIVE HEALTH repercussions. As a result, PCOS has been simultaneously over-diagnosed (diagnosing women with PCOS who have no evidence of cysts on their ovaries) and under-diagnosed (treating the reproductive health symptoms without addressing the underlying metabolic root cause that actually leads to the symptoms). The medical community has finally caught up to what so many traditional healing modality providers/practitioners and patients already knew: the old name was wrong, and it was doing real harm.

Integrative approaches including acupuncture, nutritional medicine, mind-body practices, and targeted supplementation are not adjuncts to PMOS care. For many women, they are the foundation. The name change gives us both the language and the clinical mandate to treat this condition at its roots, not just its symptoms.


After hearing from more than 22,000 people over 11 years (clinicians, researchers, and patients alike) polycystic ovarian syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS). The renaming was published in The Lancet and reflects a global consensus that the original name was scientifically inaccurate implying pathological ovarian cysts, obscuring the condition’s deep endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma.

What You Should Do Now

If you’ve been told you have “PCOS”, now PMOS, and your care has felt incomplete, you are not imagining it. A major international education campaign is now underway to reach health professionals, governments, and researchers with the updated understanding of this condition. The conversation is changing. Your care should too.

Why the Name Change Matters Clinically

An estimated 10–13% of reproductive-age women worldwide are affected, yet roughly 70% don’t know they have it. That diagnostic gap is not an accident. When a condition is named after a feature (cysts) that many patients don’t even have, clinicians and patients both miss the fuller picture. The mischaracterization has had tangible consequences: delayed diagnoses, fragmented care, stigma, and missed opportunities for early intervention in metabolic and cardiovascular risk.

Ready to explore an integrative approach to PMOS? Book a consultation with Dr. White at The Eudaimonia Center.

PMOS is not primarily a gynecological disorder. It is a complex, multisystem condition involving endocrine, metabolic, reproductive, dermatological, and psychological health. Where have you heard THAT before? Renaming it opens the door to treating it… appropriately.